THALES
Thales, the leading global technology and security provider, today announced the launch of its PQC Starter Kit in collaboration with Quantinuum (https://www.quantinuum.com). This first-of-its-kind offering helps enterprises prepare for Post-Quantum Cryptography (PQC). The kit provides a trusted environment for businesses to test quantum-hardened PQC-ready encryption keys and understand the implications that quantum computing will have on the security of their infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240123494135/en/
©Thales
While 73% of organizations recognize quantum computing poses a threat to traditional cryptography, 61% have yet to define a strategy for a post-quantum world1. Post Quantum Cryptography helps mitigate this threat. As a result, organizations around the world must test their ecosystem applications, data, and devices currently relying upon traditional cryptography to ensure minimal disruption when quantum-safe protocols become mandatory.
Todd Moore, Global Head of Data Security Products at Thales commented: “Thales is excited to offer a new solution to its customers to help them prepare for the implementation of Post-Quantum Cryptography. We understand the enormous challenges and complexities behind this upcoming disruption in cryptography and want to support customers as they transition to these new algorithms.. For organizations unsure of navigating this transition, we highly recommend testing current applications, data, and devices that use cryptographic protection as soon as possible to ensure a smooth shift to PQC. Although quantum computing may seem like a future-looking risk, with hackers using Harvest Now, Decrypt Later tactics, post-quantum resilience should be on every organization’s radar today.”
"Hardening encryption keys is critical for the post-quantum era, and Quantum Origin is a unique technology that provides verifiable quantum randomness to maximize encryption key strength. The combination of Quantum Origin and the Thales HSM is a strong solution for IT teams to help them with their PQC transition. We look forward to working with Thales to help smooth the shift to PQC,” added Duncan Jones, Head of Cybersecurity at Quantinuum.
The PQC Starter Kit will allow organizations to test within a trusted lab environment. Using the current NIST proposed algorithms that are built into the system, customers can test various security use cases including PKI, code-signing, TLS, and IoT, and observe the impact of implementing PQC technology in these simulated test-lab scenarios, all without impacting operational processes in real-world production environments. Organizations will also be able to identify potential weaknesses in their encryption deployment and apply changes to their IT infrastructure to protect themselves.
The first available PQC Starter Kit option incorporates Luna HSMs and Quantinuum’s quantum random number generation (QRNG) technology through which customers can ensure their keys are securely generated and stored while testing the PQC algorithms. The kit offers a choice of Luna HSMs (i.e. appliance or PCIe card) and Quantinuum’s Quantum Origin - the world’s only source of verified quantum entropy. A PQC Starter Kit for network encryption using Thales High Speed Encryptors (HSE) will be available next.
Learn more about the PQC Starter Kit in the customer case study here.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies within three domains: Defence & Security, Aeronautics & Space, and Digital Identity & Security. It develops products and solutions that help make the world safer, greener and more inclusive.
The Group invests close to €4 billion a year in Research & Development, particularly in key areas such as quantum technologies, Edge computing, 6G and cybersecurity.
Thales has 77,000 employees in 68 countries. In 2022, the Group generated sales of €17.6 billion.
PLEASE VISIT
Thales Group
Cloud Protection & Licensing Solutions | Thales Group
Cybersecurity Solutions | Thales Group
1 Cybersecurity Weaknesses in Data in Motion - White Paper (thalesgroup.com)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240123494135/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
FieldBee Vision wins Gold for Digital Technology Innovation at LAMMA 20269.1.2026 05:25:00 CET | Press release
FieldBee, the European leader in high-quality, easy-to-use and affordable precision agriculture technologies, proudly announces that FieldBee Vision has earned global recognition, becoming the Gold Winner in the Digital Technology Innovation of the Year category at the LAMMA Innovation Awards 2026. Lamma Show is the UK’s premier agricultural machinery, technology and equipment innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107606411/en/ FieldBee wins the LAMMA Innovation Award 2026 for Digital Technology Innovation of the Year for the FieldBee Vision (VisionSteer & VisionPro) system FieldBee Vision is part of the newly launched myFieldBee ecosystem, built to unify FieldBee’s precision farming tools and designed to connect navigation, autosteering, ISOBUS into one unified platform that supports planning, execution, monitoring and reporting. FieldBee Vision, the first modular retrofit agricultural vision system,
Survey Finds Over 70% of Chinese Doctors Recommend “AI Doctor Services” Like Ant Group’s AQ for Everyday Health Needs9.1.2026 04:31:00 CET | Press release
A recent survey by Life Times, a well-known Chinese public health media outlet, shows that AI doctor services are broadly supported by doctors in China. Among 500 physicians from the country’s top-tier (tertiary) hospitals, more than 70% said they would recommend AI doctor services to patients for everyday health questions and routine health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108456917/en/ Ant Group’s AI-native health app AQ is designed to address common, everyday health concerns and support healthy habit formation. Ant Group’s AQ was the most frequently recommended platform in the survey. The latest figures show that, as of January 2026, the app had accumulated 30 million monthly active users and answers over 10 million health-related questions daily, making it China’s leading AI-native health app. AQ—known in Chinese as Ant A-Fu—is an AI-native health app launched by Ant Group in June 2025. Desig
OPPO Joins VVC Advance Patent Pool as a Licensee and Extends HEVC Advance License9.1.2026 03:00:00 CET | Press release
Access Advance LLC and Guangdong OPPO Mobile Telecommunications Corp., Ltd. (OPPO) today announced that OPPO has joined the VVC Advance Patent Pool as a Licensee and renewed its HEVC Advance License. OPPO, one of the world's largest smartphone manufacturers with operations in more than 70 countries, has been a valued participant in Access Advance's HEVC patent pool since 2020, and more recently joined the Advance Video Distribution Patent (VDP) Pool as a Licensor. These latest agreements mark a new milestone in a broad and deepening relationship between the two companies, with OPPO now participating across all three of Access Advance's video codec licensing programs. The VVC Advance Patent Pool licenses patents essential to the VVC/H.266 standard, which delivers remarkable improvement of video compression performance over HEVC, enabling higher-quality video experiences including 4K, 8K, and HDR content with faster downloads and lower latency. The pool currently includes over 4,500 worl
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
